Study of the Effectiveness of The COVID-19 Vaccine
This descriptive study examines neutralizing antibody levels against COVID-19 in health workers before and after the 2nd booster of the COVID-19 vaccine in Surakarta, Indonesia.
|Condition or Disease
This research is a cross-sectional study with a descriptive-analytic design, community-based, of adults who live in Surakarta (age 18 years and over) using the Google form. The inclusion criteria were health workers receiving the third or second dose of the COVID-19 vaccine. Quantitative antibody titers are checked at Prodia's laboratory. Other variables examined were the number and date of vaccination, age, sex, comorbid diseases, body mass index, AEFI symptoms after the vaccine, and history of being infected with COVID-19. In the statistical analysis using the different and regression correlation tests, the significance level of P is less than 0.05.
Arms and Interventions
A health worker who received a second dose of booster COVID19 vaccine
Diagnostic Test: COVID-19 Antibody
This descriptive study examines the levels of neutralizing antibodies against COVID-19 in health workers before and after the Quantitative Anti-SARS-CoV-2 Test is an examination to measure in vitro quantitative antibodies (including IgG) against the receptor binding domain (RBD) of the SARS-CoV Spike (S) protein. -2, which aims to assess the adaptive humoral immune response to the SARS-CoV-2 Spike protein. Measurement with the ECLIA method. Ratio Scale after the 2nd booster COVID-19 vaccine in Surakarta, Indonesia.
Primary Outcome Measures
- quantitative anti-sars-cov-2 titers [Change of quantitative anti-sars-cov-2 titers before the second booster of vaccination COVID-19 and one month after]
The quantitative Anti-SARS-CoV-2 test is an examination to measure in vitro quantitative antibodies (including IgG) against the receptor binding domain (RBD) of the SARS-CoV-2 Spike protein (S) which aims to assess the adaptive humoral immune response to the SARS-CoV-2 Spike protein. Measurement with the ECLIA method. Ratio Scale
- Health workers who receive the second booster of COVID-19 vaccination
Contacts and Locations
|Universitas Sebelas Maret Hospital
Sponsors and Collaborators
- Universitas Sebelas Maret
- Principal Investigator: Nurhasan Agung Prabowo, MD, Universitas Sebelas Maret
Study Documents (Full-Text)None provided.